CLASS I Drug recall · Reported 26 Jan 2022 · FDA Enforcement Report
Senna Syrup (sennosides) 8.8 mg/ unit-dose cups recalled by Lohxa
Lohxa is recalling Senna Syrup (sennosides) 8.8 mg/ unit-dose cups, distributed nationwide in the US. The recall was initiated on 21 Dec 2021 and the FDA has classified it as Class I.
Check your package
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
Recall details
Timeline
| 21 Dec 2021 | Recall initiated by company | |
| 18 Jan 2022 | Classified by FDA | +28 days |
| 26 Jan 2022 | Published in enforcement report | +8 days |
Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.
Reason for recall
Microbial Contamination of Non-Sterile Product
A sterility recall means a product that must be sterile, such as an injection or eye drop, may be contaminated. Using a non-sterile product can cause serious infection.
Product as listed by the FDA
SENNA Syrup (sennosides) 8.8 mg/ 5 mL unit-dose cups, packaged in 24 cups per carton, Mfg for: AvKARE, TN 38478, NDC 50262-731-24.
Where it was distributed
Product was distributed to one wholesale who further distributed the product nationwide in the USA
Questions about this recall
Why was it recalled?
Microbial Contamination of Non-Sterile Product
Which lots are affected?
Lot #: AM1115S, Exp. Date 01/2023
Where was it sold?
Product was distributed to one wholesale who further distributed the product nationwide in the USA
What should I do if I have it?
Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.
What does Class I mean?
Class I is the most serious FDA recall category: there is a reasonable probability that using the product will cause serious health consequences or death.
Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.
More recalls from Lohxa
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS I | Chlorhexidine Gluconate Oral Rinse USP, 0.12%, Alcohol Free recalled | Lohxa | Sterility | FL, NY |
| Drug | CLASS II | Phenobarbital Oral Solution, USP 20 mg/, unit dose cup recalled by Lohxa | Lohxa | Other | MA, NY, WY |
| Drug | CLASS II | Bismuth Subsalicylate Oral Suspension 262mg/, unit dose cups recalled | Lohxa | Other | MA, NY, WY |
Other Senna (sennosides recalls
All 4| Reported | Class | Recall | Company | Reason | Where |
|---|---|---|---|---|---|
| Drug | CLASS II | Senna (sennosides 8.8 mg) Syrup recalled by Geritrex | Geritrex | Potency & Assay | Nationwide |
| Drug | CLASS II | Senna (sennosides 8.8 mg) Syrup recalled by Geritrex | Geritrex | Potency & Assay | Nationwide |
| Drug | CLASS II | Senna Syrup (sennosides) 8.8 mg recalled by Pharmatech | Pharmatech | Manufacturing (CGMP) Deviations | Nationwide |